Expand LXRX Menu
LXRX MENU

LXRX Latest Press Releases

-- August 6, 2026 --

Lexicon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Clinical Updates Globe Newswire 7:30 AM

-- July 30, 2026 --

Lexicon Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026 Globe Newswire 8:30 AM

-- July 27, 2026 --

Lexicon Pharmaceuticals Completes Enrollment of Pivotal Phase 3 SONATA-HCM Study of Sotagliflozin in Symptomatic Non-Obstructive and Obstructive Hypertrophic Cardiomyopathy (HCM) Globe Newswire 8:30 AM

-- June 3, 2026 --

Lexicon to Present Data at the American Diabetes Association (ADA) 2026 Scientific Sessions Globe Newswire 8:00 AM

-- May 28, 2026 --

Lexicon Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference Globe Newswire 8:30 AM

-- May 12, 2026 --

Lexicon Pharmaceuticals to Present at the 4th Annual H.C. Wainwright BioConnect Investor Conference Globe Newswire 8:30 AM

-- May 7, 2026 --

Lexicon Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Clinical Updates Globe Newswire 7:30 AM

-- May 4, 2026 --

Lexicon Pharmaceuticals Announces $100 Million Loan Facility with Hercules Capital Globe Newswire 4:05 PM

-- April 30, 2026 --

Lexicon Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026 Globe Newswire 8:00 AM

-- April 17, 2026 --

Lexicon to Present Data at the American Academy of Neurology (AAN) Annual Meeting Globe Newswire 8:00 AM

-- March 24, 2026 --

Lexicon Announces Three Presentations at the American College of Cardiology (ACC) Annual Scientific Session & Expo Globe Newswire 8:00 AM

-- March 23, 2026 --

Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851 Globe Newswire 7:30 AM
Market Data Delayed 15 Minutes